ABBOTT LABS (ABL.DE) Financials
ABL.DE Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 73.2 billion | 34.4 billion |
| 2023-09-30 | 72.1 billion | 34.4 billion |
| 2023-06-30 | 73.4 billion | 36.0 billion |
| 2023-03-31 | 73.8 billion | 36.6 billion |
ABL.DE Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 2.3 billion | 114.0 million |
| 2023-09-30 | 1.3 billion | 117.0 million |
| 2023-06-30 | 696.0 million | 132.0 million |
| 2023-03-31 | 763.0 million | 281.0 million |
ABL.DE Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 1.6 billion |
| 2023-09-30 | 1.4 billion |
| 2023-06-30 | 1.4 billion |
| 2023-03-31 | 1.3 billion |
ABL.DE Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 7.3 billion | - | 949.0 million |
| 2023-09-30 | 7.0 billion | - | - |
| 2023-06-30 | 8.2 billion | - | - |
| 2023-03-31 | 9.5 billion | - | - |
ABL.DE Shares Outstanding
ABL.DE Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 755.0 million | 700.0 million | 2.7 billion | - |
| 2023-09-30 | 560.0 million | 672.0 million | 2.7 billion | - |
| 2023-06-30 | 507.0 million | 715.0 million | 2.7 billion | - |
| 2023-03-31 | 380.0 million | 654.0 million | 2.8 billion | - |
ABL.DE Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 10.2 billion | 4.6 billion |
| 2023-09-30 | 10.1 billion | 4.6 billion |
| 2023-06-30 | 10.0 billion | 4.5 billion |
| 2023-03-31 | 9.7 billion | 4.3 billion |
ABL.DE
Price: €93.98
Dividend Yield: 0.02%
Forward Dividend Yield: 2.17%
Payout Ratio: 67.77%
Dividend Per Share: 2.04 EUR
Earnings Per Share: 2.98 EUR
P/E Ratio: 34.69
Exchange: GER
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 169.8 billion
Average Dividend Frequency: 4
Years Paying Dividends: 17
DGR3: 2.64%
DGR5: 3.37%
DGR10: 3.32%